SS

Shanthi Swaroopini Alamanda

Active Director Director DIN 09202735
DIN 09202735 First appointment Jun 2021 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Shanthi Swaroopini Alamanda

Data last updated:

Shanthi Swaroopini Alamanda is a Director at Drugelis Pharma Private Limited (since 2021). The company operates in Chemicals and Materials.

DIN 09202735
Primary Designation Director
Industry Chemicals and Materials
First Appointment 14 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drugelis Pharma Private Limited U24110AP2021PTC118519
Director14 Jun 20212021Active

Board colleagues of Shanthi Swaroopini Alamanda

NameDINCompanyDesignation
Venkata Anupama Alamanda09202734Drugelis Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drugelis Pharma Private Limited
Premium access

Shareholding and investment profile for Shanthi Swaroopini Alamanda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanthi Swaroopini Alamanda

Shanthi Swaroopini Alamanda currently holds 1 directorship: Drugelis Pharma Private Limited (Director, since 14 Jun 2021).

Shanthi Swaroopini Alamanda was first appointed on 14 Jun 2021 as Director at Drugelis Pharma Private Limited.

The current boards of Shanthi Swaroopini Alamanda's companies include Venkata Anupama Alamanda (Drugelis Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available